Access to Medicines Reform Passes House of Commons
March 10, 2011
Share this post
3 Comments

Law Bytes
Episode 138: John Lawford on the Legal, Regulatory and Policy Responses to the Rogers Outage
byMichael Geist

August 8, 2022
Michael Geist
July 18, 2022
Michael Geist
July 11, 2022
Michael Geist
Search Results placeholder
Recent Posts
The Law Bytes Podcast, Episode 138: John Lawford on the Legal, Regulatory and Policy Responses to the Rogers Outage
The Staffieri or Scott Quiz: Can You Tell the Difference Between the Rogers CEO and the CRTC Chair?
The CRTC Shrugged: A Special Law Bytes Podcast on the Industry Committee Hearing Into the Rogers Outage
The Law Bytes Podcast, Episode 136: Jeremy de Beer on SOCAN v. ESA, the Supreme Court’s Latest Endorsement of Copyright Balance and Technological Neutrality
Supreme Court of Canada on Copyright: “Copyright Law Does Not Exist Solely for the Benefit of Authors”
…
How about we fix these issues too:
http://fullcomment.nationalpost.com/2011/03/09/matt-gurney-ontario-tells-patient-to-come-back-when-shes-sicker/
Nap.
Hey Nap:
That was a great article. That is atrocious. I don’t agree with the author’s conclusion. That is, that we ditch the state-run system and go for a privatized approach. Surely any layperson can recognize that per capita many times more people go without treatment in the US than in Canada.
…
@Jesse: “I don’t agree with the author’s conclusion. That is, that we ditch the state-run system and go for a privatized approach.”
Neither do I.
Let’s summarize: She didn’t have a private insurance to cover that drug. Without the state run system she would have been completely hopeless. With the state run system her particular case didn’t went very well but at least she has a chance.
The other argument about “government is a bad manager of money”.
How comes the West European state run system costs half per capita than the US one, for similar quality services?
Nap.